Suzanne M Schoel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 454 Old Street Rd, Suite 106, Peterborough, NH 03458 Phone: 603-924-7101 Fax: 603-924-6037 |
Gregory Kriebel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 454 Old Street Rd, Suite 106, Peterborough, NH 03458 Phone: 603-924-7101 Fax: 603-924-6037 |
James M Hurley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 454 Old Street Rd, Suite106, Peterborough, NH 03458 Phone: 603-924-7101 Fax: 603-924-6037 |
Elizabeth A Shea, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 454 Old Street Rd, Suite 106, Peterborough, NH 03458 Phone: 603-924-7101 Fax: 603-924-3569 |
News Archive
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
For the seventh consecutive year, Kaiser Permanente ranked highest in customer satisfaction for health insurance among California policyholders, according to ratings firm J.D. Power & Associates.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 – the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps and in the progression of polyps to colorectal cancer.
Howard Rodgers remembers the day his son was born. His mind was teeming with positive thoughts about how this small child would change the world. Then, reality came back - for a very long visit. His son was diagnosed with one of the worst cases of autism doctors and specialists had ever seen.
Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity, such as South Africa, where COVID-19 is beginning to overwhelm intensive care units (ICUs).
› Verified 2 days ago